Federal Agricultural Mortgage's portfolio growth is shifting toward non-agricultural sectors. Find out why I’ve purchased AGM ...
QGRW ETF offers concentrated exposure to mega-cap tech, emphasizing high profitability and robust earnings growth. Read why ...
PDF Solutions' FY2025 results set new records, but valuation and chart resistance raise risks after a long rally. Check out ...
Nebius' high CapEx requirements necessitate significant capital raises, posing dilution risk, but every new capacity is pre-sold. Read why NBIS stock is a Buy.
BORR share price has generally tracked revenue growth in the past, but recent gains are unsupported by revenue growth. Based ...
Lundin Gold mine's high-grade reserves, aggressive exploration, and $100M investment may extend its 12-year life and resource ...
Newmont (NEM) is a buy after strong Q4, record 2025 FCF, rising dividends & buybacks, and attractive valuation.
Pershing Square highlights Restaurant Brands International's 2025 growth and attractive valuation. Read the full analysis for ...
CF Industries delivered strong Q4 and 2025 results, beating estimates and generating $1.8B in free cash flow. Read why CF ...
Astec Industries' organic growth stands at 5.9%, but backlog contraction and macro headwinds suggest near-term softness. Read why ASTE stock is a soft buy.
Pershing Square details Howard Hughes Holdings' transition into a diversified holding company via the $2.1 billion ...
Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results